IADR Abstract Archives

Autologous adipose tissue derived MSCs transplantation in cleft

Objectives: Cleft lip and palate is a developmental craniofacial anomaly appeared during gestation in incidence of 1 in 700. Surgical reconstruction of the bone defect is performed by bone grafting. The use of autogenous and alloplastic bone has been studied. Iliac crest as a donor site is considered as gold standard for bone grafting. The main drawback of the procedure is postoperative pain that limits walking and results in a prolonged hospitalization and recovery. The aim of the current study is to evaluate the potential of the implantation of mesenchymal stromal cells (MSCs) originated from adipose tissue to a bony defect, that imitates cleft palate in regeneration of new bone tissue in a rat model.
Methods: Adipose tissue derived MSCs were drawn from human origin and seeded on mineral particles and cells classified as osteoblasts. A bony defect was performed in the maxilla of five rats according to an accepted model and the cells were planted in 4 of the 5 rats. The rats' implanted defect were subjected to micro-CT scan followed by a histological analysis.
Results: New bone formation in the defect area was seen after 3 weeks by histological slides and in micro-CT scans.
Conclusions: Adipose tissue derived MSCs may present bone regenerating potential in maxillary defect in rat that immitate cleft plate.
Division: Israeli Division Meeting
Meeting: 2015 Israeli Division Meeting (Tel Aviv, Israel)
Location: Tel Aviv, Israel
Year: 2015
Final Presentation ID: 0021
Abstract Category|Abstract Category(s): Craniofacial Biology
Authors
  • Aizenbud, Dror  ( Technion - Israel Institute of Technology , Haifa , Israel )
  • Bendalak-mendelvitz, Hila  ( Technion - Israel Institute of Technology , Haifa , Israel )
  • Hazan-molina, Hagai  ( Technion - Israel Institute of Technology , Haifa , Israel )
  • Financial Interest Disclosure: NONE
    SESSION INFORMATION
    Oral Session
    Craniofacial
    Thursday, 06/18/2015 , 02:00PM - 03:30PM